Ginkgo Bioworks Holdings (DNA) Minority Interest (2020 - 2022)
Ginkgo Bioworks Holdings' (DNA) quarterly Minority Interest came in at $5.0 million in Q3 2022, down 92.47% YoY from $66.4 million in Q3 2021, and down 84.19% on a QoQ basis from $31.6 million in Q2 2022.
Analysis
Ginkgo Bioworks Holdings (DNA) Minority Interest (2020 - 2022) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has 3 years of Minority Interest data on file, last reported at $5.0 million in Q3 2022.
- Quarterly Minority Interest fell 92.47% year-over-year to $5.0 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $5.0 million (down 92.47% YoY) and the FY2021 annual result came in at $62.0 million, up 614.78% from the prior year.
- Minority Interest retreated to $5.0 million in Q3 2022, from $31.6 million in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $66.4 million in Q3 2021 to a low of $5.0 million in Q3 2022.
- A 3-year average of $34.5 million and a median of $32.4 million in 2022 frame the typical range for Minority Interest.
- Annual changes were most pronounced in 2021 — Minority Interest surged 614.78% — and 2022, when it plunged 92.47%.
- Tracing DNA's Minority Interest over 3 years: stood at $8.7 million in 2020, then jumped by 614.78% to $62.0 million in 2021, then slumped by 91.94% to $5.0 million in 2022.
- The last three Minority Interest figures came in at $5.0 million (Q3 2022), $31.6 million (Q2 2022), and $33.3 million (Q1 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 10 | Ginkgo Bioworks Holdings | 427.52 Mn | 342.98 Mn | 18.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | 31.63 Mn |
| Mar 31, 2022 | 33.25 Mn |
| Dec 31, 2021 | 62.01 Mn |
| Sep 30, 2021 | 66.42 Mn |
| Dec 31, 2020 | 8.68 Mn |